SLU-PP-332 5mg

SLU-PP-332 is a first-in-class ERR (Estrogen-Related Receptor) agonist, often categorized as an “exercise mimetic” or “exercise in a pill.” It targets the ERR\alpha, ERR\beta, and ERR\gamma receptors, which are metabolic regulators typically activated by physical exertion.

Primary benefits:

Metabolic Enhancement- SLU-PP-332 shifts the body’s primary fuel source from glucose to fatty acid oxidation. By increasing the burning of fat stores, it can lead to a significant reduction in fat mass without a corresponding loss of muscle tissue or a decrease in food intake.

Increased Mitochondrial Biogenesis- The peptide promotes the creation of new mitochondria in skeletal muscle. This improves cellular energy production and allows muscles to function more efficiently, effectively “tricking” the body into a physiological state similar to that of a trained athlete.

Enhanced Endurance- In preclinical studies, subjects treated with SLU-PP-332 demonstrated a marked increase in running distance and duration. It strengthens the muscle fibers’ resistance to fatigue, making it highly effective for improving aerobic capacity.

Preservation of Lean Muscle- Unlike many weight-loss interventions that risk muscle wasting (sarcopenia), SLU-PP-332 appears to protect lean mass. It encourages the body to prioritize fat for energy, which is particularly beneficial for maintaining metabolic health during weight management.

Cardioprotective Potential- By activating ERR receptors in heart tissue, the peptide may offer protective effects against certain types of heart failure by improving the organ’s energy metabolism and structural integrity.

For research purposes only